United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend ...
In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most expensive stocks insiders are dumping in March. After being in the ...
Biotechnology company United Therapeutics (NASDAQ:UTHR) in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per share was 1.2% below analysts’ consensus ...
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief ...
UNITED THERAPEUTICS ($UTHR) is expected to release its quarterly earnings data on Wednesday, February 26th before market open, per Finnhub. Analysts are expecting ...
Zacks Investment Research on MSN3d
United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound?A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback